
Company News
Jasper Therapeutics Inc (JSPR) with a beta value of 2.72 appears to be a promising investment opportunity.
On Tuesday, Jasper Therapeutics Inc (NASDAQ: JSPR) opened higher 8.26% from the last session, before settling in for the closing price of $5.45. Price fluctuations